Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
Crossref DOI link: https://doi.org/10.1007/s00125-016-3938-z
Published Online: 2016-04-01
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tonneijck, Lennart
Smits, Mark M.
Muskiet, Marcel H. A.
Hoekstra, Trynke
Kramer, Mark H. H.
Danser, A. H. Jan
Diamant, Michaela
Joles, Jaap A.
van Raalte, Daniƫl H.
License valid from 2016-04-01